|  | Conditions & Treatments | HIV & AIDS

Treatment as Prevention (TasP) for HIV: U=U Explained

What Is Treatment as Prevention (TasP)?

Using antiretroviral therapy (ART) to suppress HIV viral load to undetectable levels, thereby preventing sexual transmission. The cornerstone concept: Undetectable = Untransmittable (U=U).

Evidence Base

  • HPTN 052 (2011): 96% reduction in linked transmissions with early ART.
  • PARTNER 1 & 2 (2016, 2019): Zero linked transmissions in ~130,000 condomless sex acts (gay and straight couples) with undetectable VL.
  • Opposites Attract (2018): Zero transmissions in gay male couples.
  • Endorsed by: CDC, WHO, UNAIDS, >1,000 organizations worldwide.

Requirements for U=U

  1. Confirmed HIV diagnosis.
  2. On ART for ≥6 months.
  3. Viral load <200 copies/mL (undetectable) on two consecutive tests.
  4. Ongoing adherence & monitoring (VL every 3–6 months).

Benefits of TasP

Individual

  • Health preservation
  • Liberation from transmission fear
  • Reduced internalized stigma

Relationship

  • Condomless conception possible
  • Intimacy without anxiety
  • Shared responsibility

Public Health

  • Population-level VL reduction
  • Fewer new infections
  • Cost-effective prevention

Critical Caveats

  • Sexual transmission only. Does not apply to needle sharing, breastfeeding, or occupational exposure.
  • Other STIs still transmit. Condoms or doxy-PEP recommended.
  • Adherence is non-negotiable. Viral rebound = transmission risk returns.
  • Access gaps persist. Not all PLWH have consistent ART/VL monitoring globally.

Implementation

TasP is now central to "Ending the HIV Epidemic" initiatives. Requires: universal testing, immediate ART linkage, retention support, viral load access, and stigma reduction.

HIV & AIDS - Related Articles